白癜风患者心理共病患病率:系统综述与荟萃分析
该系统综述与荟萃分析纳入29项观察性研究、共2530例白癜风患者,评估心理症状或障碍的患病率。焦虑患病率受筛查工具类型影响,提示需在皮肤科领域验证心理筛查工具。
要点
- 白癜风患者抑郁和焦虑症状常见,汇总患病率分别约29%和33%。
- 临床诊断的抑郁和焦虑患病率低于问卷筛查结果。
- 焦虑患病率因筛查工具不同而异,需验证皮肤科专用工具。
核心结论
- 白癜风患者中一系列心理结局常见,焦虑患病率受筛查工具类型影响。
主要发现
- 研究间异质性高。
关键数值与推荐
- 最常用工具为医院焦虑抑郁量表(HADS)和流行病学研究中心抑郁量表(CES-D)。
临床怎么用
- 临床评估白癜风患者时应关注心理共病,尤其焦虑和抑郁症状。
- 选择心理筛查工具时需注意工具类型对患病率估计的影响。
局限性
- 研究间异质性高。
- 心理筛查工具在皮肤科领域尚需验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vitiligo is a chronic disorder causing skin depigmentation with global prevalence varying from 0·2% to 1·8%. U.K. guidelines recommend assessment of psychological state during clinical evaluation of vitiligo. However, the prevalence of psychological comorbidity in people with vitiligo has not been described. OBJECTIVES: To establish the prevalence of psychological symptoms or disorders in people with vitiligo and describe the outcome measures used. METHODS: We performed a comprehensive search of MEDLINE, Embase, CINAHL and PsycINFO to identify observational studies assessing the prevalence of psychological symptoms or disorders (December 2016). DerSimonian and Lard random-effects models were used to estimate the overall pooled prevalence. RESULTS: We identified 29 studies with 2530 people with vitiligo. Most studies included a measure of either depression (n = 25) or anxiety (n = 13). The commonest tools were the Hospital Anxiety and Depression Scale and the Centre for Epidemiology Studies Depression Scale. Ten studies provided information on 13 other psychological outcomes. Pooled prevalence using depression-specific and anxiety-specific questionnaires was 0·29 [95% confidence interval (CI) 0·21-0·38] and 0·33 (95% CI 0·18-0·49), respectively. Prevalence was lower for clinically diagnosed depression (0·21, 95% CI 0·15-0·28) and anxiety (0·15, 95% CI 0·06-0·24). When nonspecific tools were used the prevalence remained similar for depression (0·27, 95% CI 0·08-0·46) but increased for anxiety (0·46, 95% CI 0·39-0·52). High heterogeneity was observed. CONCLUSIONS: A range of psychological outcomes are common in people with vitiligo. The prevalence of anxiety was influenced by type of screening tool, suggesting the need for validation of psychological outcome screening tools in the field of dermatology.
引用
- Osinubi O, Grainge MJ, Hong L, et al. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 2018. PMID: 28991357. doi:10.1111/bjd.16049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。